SPONSOR
Chongqing University Cancer Hospital
Total Trials
3
Recruiting
3
Phases
Phase 4, Phase 2
Conditions studied: Radiotherapy-induced Nausea and Vomiting (RINV)Pediatric CancerNasopharyngeal CarcinomaLocally Advanced Cervical Cancer
Chongqing University Cancer Hospital is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Radiotherapy-induced Nausea and Vomiting (RINV), Pediatric Cancer, Nasopharyngeal Carcinoma, Locally Advanced Cervical Cancer.
The trial portfolio spans Phase 4, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Chongqing University Cancer Hospital
How many clinical trials has Chongqing University Cancer Hospital sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Chongqing University Cancer Hospital, of which 3 are actively recruiting participants. These trials cover conditions including Radiotherapy-induced Nausea and Vomiting (RINV), Pediatric Cancer, Nasopharyngeal Carcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Chongqing University Cancer Hospital research focus on?
Chongqing University Cancer Hospital clinical trials span Radiotherapy-induced Nausea and Vomiting (RINV), Pediatric Cancer, Nasopharyngeal Carcinoma, Locally Advanced Cervical Cancer. The research pipeline includes Phase 4, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Chongqing University Cancer Hospital clinical trial?
To participate in a Chongqing University Cancer Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Chongqing University Cancer Hospital trials with current recruitment status updated daily.
Clinical Trials by Chongqing University Cancer Hospital
NCT07217600 Phase 4
Recruiting
Ondansetron Orodispersible Film for Vomiting Prevention in Pediatric Radiotherapy
Radiotherapy-induced Nausea and Vomiting (RINV)
NCT06059261 Phase 2
Recruiting
Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.
Nasopharyngeal Carcinoma
NCT05378087
Recruiting
Comparing the Efficacy of Surgery Staging and Image Staging of Locally Advanced Cervical Cancer
Locally Advanced Cervical Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology